Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study).

Pfizer Investigational Site, Hong Kong

Pfizer Investigational Site, Taipei

Pfizer Investigational Site, Manila

Pfizer Investigational Site, Quezon City

Pfizer Investigational Site, Makati City

Pfizer Investigational Site, Glostrup Municipality

Pfizer Investigational Site, Augusta

Pfizer Investigational Site, Winter Haven

Pfizer Investigational Site, Fort Myers

Pfizer Investigational Site, Cleveland

Pfizer Investigational Site, Kfar Saba

Pfizer Investigational Site, Valencia

Pfizer Investigational Site, Indianapolis

Pfizer Investigational Site, Petah Tikva

Pfizer Investigational Site, Tel Litwinsky

Pfizer Investigational Site, Tel Aviv

Pfizer Investigational Site, Ẕerifin

Pfizer Investigational Site, Austin

Pfizer Investigational Site, San Francisco

Pfizer Investigational Site, New Delhi

Pfizer Investigational Site, Navrangpura, Ahmedabad

Pfizer Investigational Site, Coimbatore

Pfizer Investigational Site, Linz

Pfizer Investigational Site, Vienna

Pfizer Investigational Site, Ahmedabad

Pfizer Investigational Site, Seoul

Pfizer Investigational Site, Seoul

Pfizer Investigational Site, Seoul

Pfizer Investigational Site, Alicante

Pfizer Investigational Site, Barcelona

Pfizer Investigational Site, Ankara